Suzuken Co Ltd represents values of trust, integrity, and innovation. The company's corporate philosophy is focused on contributing to society through its healthcare business. Suzuken Co Ltd strives to provide high-quality products and services that improve the well-being and health of individuals. With a strong commitment to ethical business practices, Suzuken Co Ltd continually seeks to meet the evolving needs of customers and stakeholders, fostering long-term partnerships built on reliability and excellence. Through its dedication to advancing healthcare solutions, Suzuken Co Ltd aims to create a healthier and more prosperous future for all.

Suzuken Co Ltd is primarily present in Japan.

Suzuken Co Ltd, a leading stock, has achieved several significant milestones over the years. One milestone is its successful expansion into the global market, establishing a strong presence in various countries. Suzuken has also demonstrated consistent growth through strategic partnerships and mergers, enhancing its product portfolio and market position. Moreover, the company has received recognition for its commitment to innovation and quality, earning prestigious industry awards. Suzuken's consistent financial performance and ability to adapt to evolving market trends further highlight its success as a trusted player in the stock industry. As a result, Suzuken Co Ltd continues to secure its position as a market leader, driving value and growth for its shareholders.

Suzuken Co Ltd is a renowned Japanese company with a rich history and background. Established in 1921, Suzuken initially operated as a wholesale distributor for pharmaceutical products. Over the years, the company expanded its operations and diversified its portfolio. Today, Suzuken Co Ltd is a leading provider of comprehensive healthcare services, including pharmaceutical distribution, home healthcare, clinical diagnostics, and healthcare IT solutions. The company's commitment to innovation and customer-centric approach has propelled its growth and reputation in the industry. With a strong presence in Japan and expanding globally, Suzuken Co Ltd continues to play a crucial role in shaping the future of healthcare delivery.

The main competitors of Suzuken Co Ltd in the market include McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health Inc. These companies are global pharmaceutical wholesale distributors that operate in a similar industry as Suzuken. McKesson Corporation, based in the United States, is one of the largest healthcare services and information technology companies. AmerisourceBergen Corporation, also based in the United States, is a leading provider of pharmaceutical distribution and related healthcare services. Cardinal Health Inc. is another prominent player in the healthcare services and products sector, with operations in over 60 countries.

Suzuken Co Ltd is primarily active in the pharmaceutical industry.

The business model of Suzuken Co Ltd revolves around the distribution and sales of pharmaceutical and medical products in Japan. As a leading company in the healthcare industry, Suzuken operates through various segments including Pharmaceutical Wholesale, Pharmacy Chain, Medical Instruments and Equipment, and Home Healthcare. Suzuken collaborates with manufacturers to procure and distribute a wide range of pharmaceutical products to hospitals, clinics, and pharmacies across Japan. The company aims to enhance healthcare accessibility by providing high-quality medical supplies and services to customers. Suzuken's comprehensive business model enables it to contribute effectively to the healthcare system and meet the evolving needs of the Japanese market.

The P/E ratio cannot be calculated for Suzuken Co at the moment.

The P/S cannot be calculated for Suzuken Co currently.

The Quality Investing cannot be calculated for Suzuken Co at the moment.

The revenue cannot currently be calculated for Suzuken Co.

The profit cannot currently be calculated for Suzuken Co.

Suzuken Co Ltd is a Japanese company specializing in the sale and distribution of pharmaceuticals, medical devices, and diagnostic tests. The company was founded in 1934 and is headquartered in Kyoto, Japan. It operates in various segments, including pharmaceutical supply, medical device trading, diagnostic tests, and other business areas such as health and care products and the Suzuken Pharmacy chain. Suzuken has partnerships with international companies to meet the global demand for its products. It has made acquisitions and partnerships in recent years to expand its business activities and has focused on developing innovative services and technologies. Overall, Suzuken is a key player in the Japanese healthcare industry and is well-positioned to grow and expand its business in the future.

Suzuken Co pays a dividend of 0 JPY distributed over payouts per year.

The dividend cannot currently be calculated for Suzuken Co or the company does not pay out a dividend.

The ISIN of Suzuken Co is JP3398000004.

The WKN of Suzuken Co is 914027.

The ticker of Suzuken Co is 9987.T.

Over the past 12 months, Suzuken Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Suzuken Co is expected to pay a dividend of 91.46 JPY.

The current dividend yield of Suzuken Co is .

Suzuken Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

Suzuken Co paid dividends every year for the past 23 years.

For the upcoming 12 months, dividends amounting to 91.46 JPY are expected. This corresponds to a dividend yield of 1.93 %.

Suzuken Co is assigned to the 'Health' sector.

To receive the latest dividend of Suzuken Co from 6/1/2025 amounting to 50 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2025.

The last dividend was paid out on 6/1/2025.

In the year 2024, Suzuken Co distributed 76 JPY as dividends.

The dividends of Suzuken Co are distributed in JPY.